LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling

Published:2020-04 Issue:4 Volume:34 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Chen Jia¹,Li Yuanwei¹,Li Zhiqiu¹,Cao Lin²^ORCID

Affiliation:

1. Department of Urology Surgery, Hunan People's HospitalThe First Affiliated Hospital of Hunan Normal UniversityChangsha Hunan China

2. Department of Geriatrics, Hunan People's HospitalThe First Affiliated Hospital of Hunan Normal UniversityChangsha Hunan China

Funder

Natural Science Foundation of Hunan Province

The Foundation of Changsha Science and Technology Bureau

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22452

Reference60 articles.

1. Epidemiology and Risk Factors of Urothelial Bladder Cancer

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Chemotherapy for Muscle-Invasive Bladder Cancer

4. Emerging concepts on drug resistance in bladder cancer: Implications for future strategies

5. First- and Second-Line Therapy for Metastatic Urothelial Carcinoma of the Bladder

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism;Non-coding RNA Research;2024-06

2. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance;Molecular Biology Reports;2024-02-17

3. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies;Biomedicine & Pharmacotherapy;2023-09

4. Interaction between SIRT1 and non-coding RNAs in different disorders;Frontiers in Genetics;2023-06-27

5. lncRNA-mediated ceRNA network in bladder cancer;Non-coding RNA Research;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3